These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2305760)

  • 1. Quality-of-life issues for end-stage renal disease patients.
    Simmons RG; Abress L
    Am J Kidney Dis; 1990 Mar; 15(3):201-8. PubMed ID: 2305760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and rehabilitation differences among four end-stage renal disease therapy groups.
    Simmons RG; Anderson CR; Abress LK
    Scand J Urol Nephrol Suppl; 1990; 131():7-22. PubMed ID: 2075473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates.
    Julius M; Hawthorne VM; Carpentier-Alting P; Kneisley J; Wolfe RA; Port FK
    Am J Kidney Dis; 1989 Jan; 13(1):61-9. PubMed ID: 2643311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and after transplantation.
    Simmons RG; Anderson C; Kamstra L
    Am J Kidney Dis; 1984 Nov; 4(3):253-5. PubMed ID: 6388319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life of patients having renal replacement therapy.
    Niu SF; Li IC
    J Adv Nurs; 2005 Jul; 51(1):15-21. PubMed ID: 15941456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of quality of life in continuous ambulatory peritoneal dialysis and hemodialysis patients].
    Wang T; Liu B; Ye RG
    Zhonghua Nei Ke Za Zhi; 1993 Nov; 32(11):754-6. PubMed ID: 8137656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life of patients with end-stage renal failure. A comparison of hemodialysis, CAPD, and transplantation.
    Muthny FA; Koch U
    Contrib Nephrol; 1991; 89():265-73. PubMed ID: 1893735
    [No Abstract]   [Full Text] [Related]  

  • 8. End-stage renal disease treatment modality and patients' quality of life. Longitudinal assessment.
    Kutner NG; Brogan D; Kutner MH
    Am J Nephrol; 1986; 6(5):396-402. PubMed ID: 3548354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of quality of life in patients of end stage renal disease on different modalities of treatment.
    Shrestha S; Ghotekar LR; Sharma SK; Shangwa PM; Karki P
    JNMA J Nepal Med Assoc; 2008; 47(169):1-6. PubMed ID: 18552884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in end-stage renal disease: a reexamination.
    Bremer BA; McCauley CR; Wrona RM; Johnson JP
    Am J Kidney Dis; 1989 Mar; 13(3):200-9. PubMed ID: 2493190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life satisfaction across treatment methods for patients with end-stage renal failure.
    Morris PL; Jones B
    Med J Aust; 1989 Apr; 150(8):428-32. PubMed ID: 2654590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quality of life of patients with end-stage renal disease.
    Evans RW; Manninen DL; Garrison LP; Hart LG; Blagg CR; Gutman RA; Hull AR; Lowrie EG
    N Engl J Med; 1985 Feb; 312(9):553-9. PubMed ID: 3918267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life after kidney transplantation. A prospective, randomized comparison of cyclosporine and conventional immunosuppressive therapy.
    Simmons RG; Abress L; Anderson CR
    Transplantation; 1988 Feb; 45(2):415-21. PubMed ID: 3278436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of quality of life in end-stage renal disease: the time trade-off approach.
    Churchill DN; Torrance GW; Taylor DW; Barnes CC; Ludwin D; Shimizu A; Smith EK
    Clin Invest Med; 1987 Jan; 10(1):14-20. PubMed ID: 3545580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effectiveness of interventions for end-stage renal disease].
    Arredondo A; Rangel R; de Icaza E
    Rev Saude Publica; 1998 Dec; 32(6):556-65. PubMed ID: 10349148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modality transition on renal replacement therapy and quality of life of patients: a 10-year follow-up cohort study.
    de Brito DCS; Machado EL; Reis IA; Moreira DP; Nébias THM; Cherchiglia ML
    Qual Life Res; 2019 Jun; 28(6):1485-1495. PubMed ID: 30666548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal replacement therapies in the elderly: Part 1. Hemodialysis and chronic peritoneal dialysis.
    Ismail N; Hakim RM; Oreopoulos DG; Patrikarea A
    Am J Kidney Dis; 1993 Dec; 22(6):759-82. PubMed ID: 8250022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological, physical, and psychosocial functioning of individuals with end-stage renal disease.
    Bremer BA; Wert KM; Durica AL; Weaver A
    Ann Behav Med; 1997; 19(4):348-52. PubMed ID: 9706361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire.
    Wu AW; Fink NE; Cagney KA; Bass EB; Rubin HR; Meyer KB; Sadler JH; Powe NR
    Am J Kidney Dis; 2001 Jan; 37(1):11-21. PubMed ID: 11136162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.